ANL

Adlai Nortye Ltd.

There isn't enough reported data to score ANL yet.

ANL Fundamentals

MetricStatus
Unavailable
Weak
Weak
Unavailable

ANL's profitability and cash flow are currently weak. There isn't enough data to rate its revenue and balance sheet.

ANL PE Valuation

ANL has no meaningful PE right now: it lost money over the past year.

ANL Forward outlook

There aren't enough analyst estimates for ANL to show an outlook.

ANL Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $10.52 on Nov 12.

There is not enough scenario data to assess ANL's risk to reward.

ANL Earnings Per Share

Q3 2023: $-13.72Q4 2023: $-14.01Q1 2024: $-14.40Q2 2024: $-7.68Q3 2024: $-6.39Q4 2024: $-5.10Q1 2025: $-4.38Q2 2025: $-3.66Q3 2025: $-3.51Q4 2025: $-3.36Q1 2026: $-2.66Q2 2026: $-1.96
Q3 2023: $-13.72Q4 2023: $-14.01Q1 2024: $-14.40Q2 2024: $-7.68Q3 2024: $-6.39Q4 2024: $-5.10Q1 2025: $-4.38Q2 2025: $-3.66Q3 2025: $-3.51Q4 2025: $-3.36Q1 2026: $-2.66Q2 2026: $-1.96
QuarterTTM EPSYoY
Q2 2026-$1.96+$1.70
Q1 2026-$2.66+$1.72
Q4 2025-$3.36+$1.74
Q3 2025-$3.51+$2.88
Q2 2025-$3.66+$4.02
Q1 2025-$4.38+$10.02
Q4 2024-$5.10+$8.91
Q3 2024-$6.39+$7.33

ANL is still losing money, but far less than before: $1.96 per share over the past year, against $14.40 at its worst in early 2024.

ANL Quarterly Revenue

Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $3MQ4 2025: $3MQ1 2026: $7MQ2 2026: $7M
Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $3MQ4 2025: $3MQ1 2026: $7MQ2 2026: $7M

ANL's revenue has grown year over year for four quarters in a row: $7M last quarter.

ANL Free Cash Flow

Q3 2023: −$19MQ4 2023: −$19MQ1 2024: −$14MQ2 2024: −$14MQ3 2024: −$12MQ4 2024: −$12MQ1 2025: −$8MQ2 2025: −$8MQ3 2025: −$9MQ4 2025: −$34MQ1 2026: −$8MQ2 2026: −$8M
Q3 2023: −$19MQ4 2023: −$19MQ1 2024: −$14MQ2 2024: −$14MQ3 2024: −$12MQ4 2024: −$12MQ1 2025: −$8MQ2 2025: −$8MQ3 2025: −$9MQ4 2025: −$34MQ1 2026: −$8MQ2 2026: −$8M
QuarterFree cash flowYoY
Q2 2026-$7.7M-$116.5K
Q1 2026-$7.7M-$116.5K
Q4 2025-$33.6M-$21.8M
Q3 2025-$9.3M+$2.6M
Q2 2025-$7.6M+$6.7M
Q1 2025-$7.6M+$6.7M
Q4 2024-$11.8M+$7.4M
Q3 2024-$11.8M+$7.4M

ANL has burned cash in almost every quarter: −$58M over the past year, against −$39M the year before.

ANL Total Shares

Q3 2023: 7MQ4 2023: 7MQ1 2024: 9MQ2 2024: 9MQ3 2024: 13MQ4 2024: 13MQ1 2025: 11MQ2 2025: 11MQ3 2025: 11MQ4 2025: 11MQ1 2026: 16MQ2 2026: 16M
Q3 2023: 7MQ4 2023: 7MQ1 2024: 9MQ2 2024: 9MQ3 2024: 13MQ4 2024: 13MQ1 2025: 11MQ2 2025: 11MQ3 2025: 11MQ4 2025: 11MQ1 2026: 16MQ2 2026: 16M
PeriodChange %Net change
Quarterly0%--
1 year+49%+5.3M shares
3 years+108%+8.3M shares

ANL has 16M diluted shares, up 49% from a year ago.

ANL Net Leverage

ANL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

ANL Weekly Momentum

MetricValueStatus
RSI44.3Neutral
Stochastic13.3Oversold

ANL's weekly RSI is 44 (neutral) and its Stochastic is 13 (oversold).

ANL PE vs Healthcare Sector

ANL has no meaningful PE right now: it lost money over the past year.

ANL Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$12.314% below
20 week MA$12.717% below
50 week MA$10.14.6% above
100 week MA$5.9477% above

ANL has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 77% above its 100-week average.

ANL Yearly ROI

YearStart priceEnd priceROI
2023$15.0$8.99-40%
2024$8.99$2.40-73%
2025$2.40$1.64-32%
2026 YTD$1.64$10.5+541%

ANL has finished every year since 2023 lower, and it's up 541% so far in 2026.

Give your agent the market.

Get API key